Analysts expect revenue increase Merck KGaA

Tomorrow the German Merck KGaA KGaA will report its past quarter's results. For this year Merck KGaA KGaA's revenue will be around 15,33 billion euros. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 15,02 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2018

The analysts expect for 2018 a net profit of 2,57 billion euros. For this year the consensus of the result per share is a profit of 6,22 euros. The price/earnings-ratio therefore equals 12,61.

For this year the analysts expect a dividend of 1,28 euros per share. Thus the dividend yield equals 1,63 percent. The average dividend yield of the pharmaceutical companies is a low 1 percent.

Most recent target prices around 94 euros

Barclays , M.M. Warburg & Co. and JP Morgan recently provided recommendations for the stock.

Merck KGaA KGaA's market capitalization is based on the number of outstanding shares around 10,14 billion euros.

At 10.41 the stock trades 0,13 percent higher at 78,46 euros.

Historical stock prices Merck KGaA KGaA past 10 years

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.